谷歌浏览器插件
订阅小程序
在清言上使用

A Randomized Phase 3 Study Comparing P2B001 to Its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease

MOVEMENT DISORDERS(2024)

引用 1|浏览35
关键词
Parkinson's disease,pramipexole,rasagiline
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要